Om Mehra, tech analyst at SAMCO Securities highlights that Torrent Pharmaceuticals after a recent consolidation phase, has witnessed a strong breakout above ₹4,200 levels.
Torrent Pharma reported a 26.2 per cent jump in its net profit to ₹635 crore in Q3FY26. On a sequential basis, profit increased 7.4 per cent from ₹591 crore
Ahmedabad-based drugmaker reports Rs 635 crore Q3 profit on strong India, Brazil and US growth; revenues rise 17.6% to Rs 3,303 crore
Torrent Pharma Q3 revenue from operations increased 17.7 per cent year-on-year (Y-o-Y) to ₹3,251 crore from ₹2,762 crore in Q3FY25
Nifty price prediction Feb 4: Key support at 25,500, resistance near 26,200. Also read Bank Nifty outlook, Nifty options data, and Chandan Taparia stock picks